SIC
ADPT icon

SJS Investment Consulting’s Adaptive Biotechnologies ADPT Stock Holding History

SJS Investment Consulting’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.31K Buy
294
+166
+130% +$2.54K ﹤0.01% 1287
2026
Q1 		$1.78K Hold
128
– – ﹤0.01% 1305
2025
Q4 		$2.08K Sell
128
-42
-25% -$685 ﹤0.01% 1142
2025
Q3 		$2.54K Buy
+170
New +$2.07K ﹤0.01% 783
2022
Q4 		– Sell
-36
Closed – – 1593
2022
Q3 		$0 Buy
+36
New +$339 ﹤0.01% 999

Other funds holding ADPT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return
GIP
Granite Investment Partners El Segundo, California $1.95B AUM 49.89% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

SJS Investment Consulting's ADPT Position: Q2 2026 in Review

SJS Investment Consulting increased its Adaptive Biotechnologies (ADPT) stake by 130% in Q2 2026, buying an estimated $2.54K and bringing the position to 294 shares worth $6.31K. The position accounts for ﹤0.01% of the portfolio, ranked #1287.

SJS Investment Consulting first reported a position in ADPT in Q3 2022 and has held it in 5 quarters since. 132 funds tracked by Wall St. Rank hold ADPT as of Q2 2026.

  • SJS Investment Consulting held 294 shares of Adaptive Biotechnologies worth $6.31K as of Q2 2026.
  • SJS Investment Consulting bought 166 Adaptive Biotechnologies shares in Q2 2026, an estimated $2.54K.
  • Adaptive Biotechnologies made up ﹤0.01% of SJS Investment Consulting's portfolio in Q2 2026, its #1287 holding.
  • SJS Investment Consulting first reported a position in Adaptive Biotechnologies in Q3 2022 and has held it in 5 quarters since.
  • 132 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q2 2026.

Based on SJS Investment Consulting's 13F filing for Q2 2026, filed 22 Jul 2026.